2m 2m 2m 2m 2m 2m 2m
CARIS (CAI)
NASDAQ
$17.59+$0.28 (+1.61%)
Price as of Jun 23, 2026 1:37 PM EDT- $4.9BMarket Cap
- -33.27%1-Year Change
- BiotechnologyIndustry
CARIS (CAI)
$17.59+$0.28 (+1.61%)
CAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.31 | ||
Change | -$1.16 (-6.28%) | ||
Open | $18.61 | ||
High | $18.79 | ||
Low | $17.27 | ||
Previous Close | $18.47 | ||
Volume | 3,023,468 | ||
30-Day Average Volume | 2,518,326 | ||
1-Week Change | -4.79% | ||
1-Month Change | 11.32% | ||
1-Year Change | -33.27% | ||
3-Year Change | -69.09% | ||
5-Year Change | -69.02% | ||
Fundamentals | |||
Shares Outstanding | 282.7M | ||
Total Assets | $1.2B | ||
Market Cap | $4.9B | ||
Enterprise Value | $4.5B | ||
Period: QTR TTM FY | |||
Revenue | $210.8M | ||
Net Income | -$510,000.00 | ||
Free Cash Flow | $22.5M | ||
EBIT | $12.2M | ||
EBITDA | $17.2M | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 259 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 8 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 217 | ||
Price/Operating Cash Flow | 149 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/09/2021 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield